Group 1: Company Announcements - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan, including a reconstruction compensation investment of about 2.228 billion yuan [1] - Fushun Special Steel announced that Ningbo Meishan Bonded Port Area Jincheng Shazhou intends to make a partial tender offer to acquire 5% of the company's shares at a price of 5.6 yuan per share [2] - China Duty Free Group reported a net profit of 2.6 billion yuan for the first half of 2025, a year-on-year decrease of 20.81%, with total operating revenue of 28.151 billion yuan, down 9.96% [3] - Gaozheng Mining announced that its controlling shareholder, Cangjian Group, reduced its shareholding by 2.76 million shares, bringing its stake down to 57.6% [4] - Sanfeng Intelligent reported that its director Chen Wei is under investigation, but the company's operations remain normal [5] - Guangsheng Group's innovative hepatitis B treatment drug GST-HG141 has successfully enrolled its first participant in a Phase III clinical trial [6] - Western Gold announced plans to acquire 100% of Xinjiang Meisheng for 1.655 billion yuan, with a premium of 1421.66% over the book value [7] - Huqin Technology announced that shareholders holding more than 5% plan to reduce their holdings by up to 4% of the company's shares [8] - Dongshan Precision's subsidiary plans to invest up to 1 billion USD in a high-end printed circuit board project [10] - Yitian Intelligent plans to jointly invest in a private equity fund focusing on artificial intelligence and computing power, with a total subscription amount of 2 billion yuan [11] - *ST Wanfang is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [12] - Ruibeka and its controlling shareholder are also under investigation by the CSRC for similar reasons [13] - BioShares' subsidiary received clinical trial approval for a cat infectious peritonitis mRNA vaccine [14] - Ruipu Bio received the first clinical trial approval for an mRNA vaccine for economic animals in China [15] - Shengke Communication announced that a major fund plans to reduce its holdings by up to 3% of the company's shares [16] - ShenKai Co. announced a capital increase of 15 million yuan in Shandong Future Robotics, a deep-sea operation robot company [18] - Shouchuang Securities plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance capital strength [19] Group 2: Financial Performance - Western Mining reported a net profit of 1.869 billion yuan for the first half of the year, a year-on-year increase of 15% [20] - Digital Certification expects a loss of 80 million to 96 million yuan for the first half of the year [21] Group 3: Major Contracts and Share Buybacks - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [22] - Zhejiang Communications Technology's subsidiary won two projects totaling over 3.4 billion yuan [23] - Feilong Co. received a notification from SAIC Motor for a designated sales agreement, expecting sales revenue of over 400 million yuan during its lifecycle [24] - Liuyuan Group plans to repurchase shares worth 100 million to 200 million yuan [25] - Meikailong's shareholders plan to reduce their holdings by no more than 3.0011% of the company's shares [26]

Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]

Corporate Announcements - Sanfeng Intelligent's director Chen Wei has been placed under investigation, but the company's operations remain normal and unaffected [3] - Shanghai Pharmaceuticals plans to acquire a 10% stake in Shanghai Shihua Group Financial Company for 143 million yuan, increasing its ownership from 30% to 40% [4] - Western Gold intends to acquire 100% of Xinjiang Meisheng Mining for 1.655 billion yuan, with a premium of 1421.66% over book value; the target company is expected to commence production in the second half of 2025 [5] - Hengrui Medicine plans to acquire approximately 1.46% of Chengdu Shengdi Pharmaceutical from minority shareholders for 40.144 million yuan, increasing its stake to 97.37% [6] - Dongshan Precision has approved an investment of up to 1 billion USD for a high-end printed circuit board project to meet long-term demand in emerging markets [7] - ST Wanfang and Rebecca have both received notices from the China Securities Regulatory Commission regarding investigations into information disclosure violations, but their operations remain normal [8][9] Financial Performance - China Duty Free Group reported a net profit of 2.6 billion yuan for the first half of 2025, a decrease of 20.81% year-on-year, with total revenue of 28.151 billion yuan, down 9.96% [13] - Digital Certification expects a loss of 80 to 96 million yuan for the first half of 2025, compared to a loss of 29.25 million yuan in the same period last year [14] - Western Mining reported a net profit of 1.869 billion yuan for the first half of 2025, an increase of 15% year-on-year, with total revenue of 31.619 billion yuan, up 27% [15] Major Contracts - ST Dongyi signed new orders worth 215 million yuan in the second quarter for its decoration business, with total uncompleted contracts amounting to 383 million yuan [17] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project, with a total investment of approximately 16.66 billion yuan [18] Shareholder Actions - Huajin Technology's employee stock ownership platform plans to reduce its stake by up to 4% within three months [20] - Liuyuan Group intends to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.7 yuan per share [22]

证券代码：601333 证券简称：广深铁路 公告编号：2025-009 广深铁路股份有限公司 关于签订广州东站改造项目合作协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本合作协议为各方基于合作意愿达成的初步约定，协议相关金额皆为预估 或暂定数值，具体合作事宜尚待本协议所涉及的相关事项具体明确，并经各方依 法履行内部决策程序审议通过后再签订具体交易协议进行约定，具体交易协议的 实施内容和进度尚存在不确定性。 本项目投入规模较大、合作期限较长，项目实施进度和预期结果有可能受 到政策调整、市场变化、各方履约能力等不可预测或不可抗力等不确定性因素的 影响。 本合作协议涉及本公司的相关具体内容包括但不限于广州东站既有资产 （含土地）处置、对外投资与其他方共同组建项目公司、所参股铁城公司资产处 置及还建、公司所属石牌客整所土地上盖综合开发。当上述具体事项实际发生并 会计确认时，预计对本公司的财务状况和经营结果产生重大影响，具体涉及年度 （当年或未来年度）将视具体项目后续进展而定。 本公司将密切关注本合作协议履 ...

广深铁路（601333）公告，公司与广州市政府、广铁集团签订了广州东站改造项目合作协议。项目总投 资约166.6亿元，合作期限较长，预计对公司的财务状况和经营结果产生重大影响。项目包括广州东站 既有资产处置、对外投资、共同组建项目公司、铁城公司资产处置及还建、石牌客整所土地上盖综合开 发等。项目实施进度和预期结果可能受政策调整、市场变化等因素影响。 ...

Group 1 - The core viewpoint of the news is that fund manager Yang Siliang oversees 13 funds, with the best-performing fund being the Baoying Enhanced Income Bond A/B, which experienced a net value drop of 0.01% in the second quarter of 2025 [1][2] - Yang Siliang's funds have varying annualized returns, with the highest being 14.57% for Baoying New Value Mixed A, while the Baoying Enhanced Income Bond A/B has a return of 5.64% [2] - The performance of Yang Siliang's funds shows a range of quarterly declines, with the worst being a drop of 5.83% for Baoying Brand Consumption Stock C [2] Group 2 - Yang Siliang's management of the Baoying Consumption Theme Mixed Fund has yielded a cumulative return of 144.0% with an average annualized return of 14.16% [2] - The fund manager has made 69 adjustments to heavy-weight stocks during his tenure, achieving a success rate of 69.57% with 48 profitable trades [2] - Notable stock adjustments include significant gains from stocks like Longi Green Energy and Ningde Times, with estimated returns of 236.94% and 81.86% respectively [3][5][6] Group 3 - The news also highlights some unsuccessful stock adjustments, such as the investment in Zijin Mining, which resulted in an estimated loss of 57.48% despite the company showing a profit growth of 51.76% [7] - Other stocks that underperformed include Zonghui Mining and Gongdong Medical, with estimated losses of 50.94% and 47.41% respectively [4][7]

6月18日，广深铁路（SH601333，股价2.90元，市值205.42亿元）在深圳总部举行"2024年度股东周年大会"。该公司是国内唯一同时在上海、香港两地上市 的铁路运输企业，多位中小股东到场参会，与公司管理层热切交换意见。 就参会股东关心的广州东站改造进度，广深铁路董秘唐向东回应称，广州东站改造的主要难点在于：这是在既有的繁忙线路上原址改造，需要做大量前置工 作，包括寻找货运和客运的替代渠道。广州东站相关的既有资产涉及上市公司利益，很多内容经过反复研究，用时也较长，"大家做了大量工作，我们离目 标越来越近"。 图片来源：每经记者 孔泽思 摄 铁路货运正向现代物流转型 广深铁路主要经营铁路客货运输业务。2024年，公司完成旅客发送量6910.67万人，同比增长16.51%；完成货物发送量1409.98万吨，同比下降12.05%。 每经记者｜孔泽思 每经编辑｜张海妮 在股东大会现场，唐向东向《每日经济新闻》记者分析指出，货运收入在公司营收中的比重较低，2024年公司营业收入为270.90亿元，其中货运收入仅为 16.23亿元，货运收入情况对整个公司经营业绩影响有限。 唐向东认为今年铁路运输面临诸多机遇。他表 ...

北京市海问（深圳）律师事务所 关于广深铁路股份有限公司 致：广深铁路股份有限公司 根据《中华人民共和国证券法》、 《中华人民共和国公司法》 （以下统称"有关 法律"）及《广深铁路股份有限公司章程》 （以下简称"公司章程"）的规定，北京 市海问（深圳）律师事务所（以下简称"本所"）受广深铁路股份有限公司（以下 简称"公司"）的委托，指派本所律师列席公司于 2025 年 6 月 18 日召开的 2024 年度股东周年大会（以下简称"本次会议"）现场会议，对本次会议召开的合法性 进行见证，并依法出具本法律意见书。 电话(Tel): (+86 755) 8323 6000 传真(Fax)：(+86 755) 8323 0187 www.haiwen-law.com 北京 BEIJING 丨上海 SHANGHAI 丨深圳 SHENZHEN 丨香港 HONG KONG 丨成都 CHENGDU 公司提交给本所律师的资料（包括但不限于有关人员的居民身份证、股票账 户卡、授权委托书、营业执照、网络投票结果等）真实、完整，资料上的签字和 /或印章均是真实的，资料的副本或复印件均与正本或者原件一致。 本所律师按照律师行业公认的业务 ...

(一) 本次股东大会见证的律师事务所：北京市海问（深圳）律师事务所 律师：苏兰、高小敏 (二) 律师见证结论意见： 本次会议召集和召开的程序、召集人的资格、出席本次会议现场会议的股东（含股东授 权代表）的资格和本次会议的表决程序均符合有关法律和《公司章程》的有关规定，本次会 议的表决结果合法、有效。 特此公告。 | 证券代码：601333 证券简称：广深铁路 | | 公告编号：2025-008 | | | | | --- | --- | --- | --- | --- | --- | | 广深铁路股份有限公司 | | | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 | | | | | | | 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | | | | | | | 重要内容提示： | | | | | | | ? 本次会议是否有否决议案：无 | | | | | | | 一、会议召开和出席情况 | | | | | | | (一) 股东大会召开的时间：2025 年 6 月 18 日 | | | | | | | (二) 股东大会召开的地点：广东省深圳市罗湖区和 ...

北京市海问（深圳）律师事务所 关于广深铁路股份有限公司 2024 年度股东周年大会的法律意见书 致：广深铁路股份有限公司 根据《中华人民共和国证券法》、《中华人民共和国公司法》（以下统称"有关 法律"）及《广深铁路股份有限公司章程》（以下简称"公司章程"）的规定，北京 市海问（深圳）律师事务所（以下简称"本所"）受广深铁路股份有限公司（以下 简称"公司"）的委托，指派本所律师列席公司于 2025 年 6 月 18 日召开的 2024 年度股东周年大会（以下简称"本次会议"）现场会议，对本次会议召开的合法性 进行见证，并依法出具本法律意见书。 本所及经办律师依据《中华人民共和国证券法》、《律师事务所从事证券法律 业务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及本法 律意见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤 勉尽责和诚实信用原则，进行了充分的核查验证，保证本法律意见书所发表的结 论性意见合法、准确，不存在虚假记载、误导性陈述或者重大遗漏，并承担相应 法律责任。 在本法律意见书中，本所律师仅对本次会议召集和召开的程序、出席本次会 议现场会议人员的资格及表决程序是否符合 ...